TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
WGS

GeneDx Holdings Corp.

Healthcare · Diagnostics & Research

88.50$ +3.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet WGS
Line item 2019 2020 2021 2022 2023 2024 2025
– 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– 69.2% 87.3% 39.0% 43.5% 47.2% 47.1%
– 43.0% 72.3% 25.2% 23.8% 20.3% 18.4%
– 43.0% 72.3% 25.2% 31.1% 33.7% 30.0%
– 12.8% 4.8% 7.9% 7.8% 9.0% 13.0%
– 9.9% 6.0% 2.5% 2.1% 2.5% 2.4%
– 25.1% 11.3% 15.5% – – –
– – – – – 0.0% 2.4%
– – – 34.2% 41.2% 37.8% 29.5%
– 98.3% 30.0% 53.5% 45.5% 41.5% 46.0%
– 29.2% 18.3% 26.5% 14.0% 13.1% 19.1%
– 1.4% 0.6% 2.0% 1.0% 0.8% 1.6%
– 10.6% 8.1% 8.4% 2.4% 1.9% 0.4%
– 7.5% 2.0% 1.1% 12.6% 12.4% 8.4%
– 1.7% 70.0% 46.5% 54.5% 58.5% 54.0%
– -131.2% -103.9% -206.2% -310.5% -322.5% -240.9%
– 2.2% 0.6% 1.9% 5.8% 6.4% 4.7%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?